Search filters

Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response o

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description article
Author/s

author: Hagop Kantarjian  Andreas Hochhaus 

Publication date February 2010
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item